French pharmaceutical brand Bioderma has introduced a new product, Atoderm AD Intensive Baume, following extensive research into eczema. The brand's research and a study of 500 eczema sufferers were presented at last month's EADV (European Academy of Dermatology and Venereology) conference in Vienna.
Bioderma suggests that eczema-compromised skin lacks a precise combination of 15 lipids, which the new product aims to replace. The lotion is patented and approved for use on babies.
Trial results for Atoderm AD Intensive Baume showed that it soothed itching from the first application and reduced the urge to scratch by 88%. The product is also described as comforting and moisturising for general dry skin.